Lipid Changes during 26-Wk Treatment with the Novel Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) or Insulin NPH in 6 IMAGINE Trials

被引：0
|
作者：
Ginsberg, Henry
Cariou, Bertrand
Orchard, Trevor J.
Chen, Lei
Luo, Junxiang
Bastyr, Edward J., III
Bue-Valleskey, Juliana
Chang, Annette M.
Ivanyi, Tibor
Jacober, Scott J.
Jacobson, Jennie G.
Hoogwerf, Byron J.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
990-P
引用
下载
收藏
页码：A251 / A251
页数：1
相关论文
共 44 条
  • [1] Lipid changes during 26-week treatment with the novel basal insulin peglispro (BIL) vs insulin glargine or NPH insulin in 6 IMAGINE Trials
    Hoogwerf, B. J.
    Ginsberg, H.
    Cariou, B.
    Orchard, T.
    Chen, L.
    Luo, J.
    Bastyr, E. J., III
    Bue-Valleskey, J.
    Chang, A. M.
    Jacober, S. J.
    Jacobson, J. G.
    Ivanyi, T.
    DIABETOLOGIA, 2015, 58 : S80 - S81
  • [2] Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
    Ginsberg, Henry
    Cariou, Bertrand
    Orchard, Trevor
    Chen, Lei
    Luo, Junxiang
    Bastyr, Edward J., III
    Bue-Valleskey, Juliana
    Chang, Annette M.
    Ivanyi, Tibor
    Jacober, Scott J.
    Hoogwerf, Byron J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1089 - 1092
  • [3] Similar Counterregulatory Hormone Responses to Hypoglycemia with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in Type 1 Diabetes
    Heise, Tim
    Kapitza, Christoph
    Nosek, Leszek
    Lam, Eric Chen Quin
    Choi, Siak Leng
    Garhyan, Parag
    Jacober, Scott J.
    Porksen, Niels
    Prince, Melvin J.
    Linnebjerg, Helle
    DIABETES, 2015, 64 : A252 - A253
  • [4] Reduced nocturnal hypoglycaemia with basal insulin peglispro (BIL) compared to insulin glargine (GL): pooled analyses of 5 randomised controlled trials
    Marre, M.
    Rosenstock, J.
    Qu, Y.
    Jacober, S. J.
    Prince, M. J.
    Chang, A. M.
    Bastyr, E. J., III
    DIABETOLOGIA, 2015, 58 : S474 - S475
  • [5] Reduced Nocturnal Hypoglycemia (Hypo) with Basal Insulin Peglispro (BIL) Compared with Insulin Glargine (GL): Pooled Analyses of 5 Randomized Controlled Trials
    Rosenstock, Julio
    Marre, Michel
    Qu, Yongming
    Jacober, Scott J.
    Prince, Melvin J.
    Chang, Annette M.
    Bastyr, Edward J., III
    DIABETES, 2015, 64 : A254 - A254
  • [6] Effect of exercise on Pharmacokinetics (PK) of Basal Insulin peglispro (BIL) and insulin Glargine (GL) in type 1 diabetes mellitus patients
    Linnebjerg, H.
    Lam, E.
    Choi, S.
    Knadler, M. P.
    Porksen, N.
    Sinha, V. P.
    Garhyan, P.
    Klein, O.
    Nosek, L.
    Heise, T.
    DIABETOLOGIA, 2015, 58 : S164 - S164
  • [7] Basal Insulin peglispro (BIL) demonstrates hepato-preferential action vs insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Mudaliar, S.
    Henry, R. R.
    Ciaraldi, T. P.
    Armstrong, D. A.
    Burke, P. M.
    Pettus, J. H.
    Garhyan, P.
    Choi, S. L.
    Jacober, S. J.
    Knadler, M. P.
    Lam, E. C. Q.
    Prince, M. J.
    Bose, N.
    Porksen, N. K.
    Linnebjerg, H.
    DIABETOLOGIA, 2015, 58 : S1 - S1
  • [8] Superior HbA1c reduction with Basal Insulin peglispro (BIL) vs insulin glargine in patients with type 2 diabetic patients previously treated with basal insulin: IMAGINE 5
    Trescoli Serrano, C.
    Buse, J. B.
    Rodbard, H. W.
    Luo, J.
    Ivanyi, T.
    Bue-Valleskey, J.
    Hartman, M. L.
    Carey, M. A.
    Chang, A. M.
    DIABETOLOGIA, 2015, 58 : S470 - S470
  • [9] Superior HbA1c Reduction with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) Alone or with Oral Antihyperglycemic Medications (OAMs) in T2D Patients (Pts) Previously Treated with Basal Insulin: IMAGINE 5
    Buse, John B.
    Rodbard, Helena W.
    Serrano, Carlos Trescoli
    Luo, Junxiang
    Ivanyi, Tibor
    Bue-Valleskey, Juliana
    Hartman, Mark L.
    Carey, Michelle A.
    Chang, Annette M.
    DIABETES, 2015, 64 : A249 - A250
  • [10] Superior Reduction of HbA1c in a Double-Blind, Randomized Study of Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in Patients (pts) with T1D: IMAGINE
    Bergenstal, Richard M.
    Lunt, Helen
    Franek, Edward
    Travert, Florence
    Mou, Jiani
    Hartman, Mark L.
    Rosilio, Myriam
    Bastyr, Edward J., III
    DIABETES, 2015, 64 : A250 - A250
12345